Apr 25 |
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
|
Apr 25 |
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
|
Apr 24 |
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
|
Apr 24 |
Sector Update: Health Care Stocks Slipping Late Afternoon
|
Apr 24 |
Novo Nordisk comes under Senate probe over pricing for weight loss drugs
|
Apr 24 |
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
|
Apr 24 |
Weight Loss Leader Novo Nordisk Hits Buy Trigger In Stock Market Rebound
|
Apr 24 |
3.6M Medicare patients could qualify for Wegovy coverage: report
|
Apr 24 |
4 Large Drug Stocks to Hold on to Amid Industry Challenges
|
Apr 24 |
Novo Nordisk A/S – Reduction of the share capital
|